The U.S. Food and Drug Administration has granted clearance to an artificial intelligence-driven CT tool used to diagnose and track brain injuries.
Qure.ai—headquartered in New York and Mumbai—announced the news Thursday, gaining 510(k) clearance for its brain CT quantification software qER-Quant.
Clinicians using this platform can assess the severity of numerous brain conditions, including hemorrhagic stroke, hydrocephalus and traumatic brain injuries. The software can also track the progression of such injuries.
Read more at: https://www.healthimaging.com/topics/ai-emerging-technologies/ai-qureai-fda-clearance-brain-injury-ct
